Aflac Incorporated's Stock Analysis

Aflac Issues Senior Notes with Various Maturities and Rates

Aflac Incorporated has issued a total of ¥66,900,000,000 in Senior Notes, which include four different series due in 2029, 2031, 2033, and 2036, with interest rates ranging from 2.117% to 3.482%. The proceeds from this public offering will be used for general corporate purposes, and the Notes are unsecured obligations that will rank equally with the company's existing and future unsecured senior debt.

Interest on the Notes will be paid semi-annually starting November 28, 2026, with specific call dates for early redemption. The issuance was conducted under an underwriting agreement with several financial institutions acting as representatives. The Notes are governed by a Base Indenture and several supplemental indentures, which outline customary events of default and other provisions related to the Notes.

May 28, 2026 16:35:43

Aflac Issues $500 Million in Senior Notes Due 2036

Aflac Incorporated has issued $500 million in aggregate principal amount of 5.150% Senior Notes, which are set to mature in 2036. The company intends to use the net proceeds from this offering for general corporate purposes. Interest on the Notes will be paid semi-annually, with the first payment scheduled for November 14, 2026.

The Notes are general unsecured obligations of Aflac and rank equally with the company's existing and future unsecured senior debt. The company has the option to redeem the Notes before their maturity date under specific conditions, including a Par Call Date set for February 14, 2036. The offering was conducted under an underwriting agreement with major financial institutions acting as representatives.

May 14, 2026 17:11:06

Aflac Issues $500 Million Senior Notes with 5.150% Interest

Aflac Incorporated has issued $500 million in aggregate principal amount of 5.150% Senior Notes due in 2036. The proceeds from this public offering will be used for general corporate purposes. The Notes will pay interest semi-annually, starting November 14, 2026, and may be redeemed by the company under specific conditions prior to their maturity date.

The Notes are unsecured obligations and rank equally with the company's existing and future unsecured senior debt. They were issued under an indenture that includes standard events of default, such as nonpayment and bankruptcy. The underwriting of this offering was managed by Goldman Sachs & Co. LLC, Mizuho Securities USA LLC, SMBC Nikko Securities America, Inc., and Wells Fargo Securities, LLC.

May 14, 2026 17:11:06

Aflac Shareholders Approve Board and Compensation Proposals

Aflac Incorporated held its Annual Shareholders Meeting on May 4, 2026, where shareholders voted on several key proposals. The shareholders approved the election of 11 board members, an advisory proposal on executive compensation, and the appointment of KPMG LLP as the independent accounting firm for the year ending December 31, 2026. However, a proposal for an independent board chairman was not approved.

At the meeting, a total of 515,183,672 shares were entitled to vote, with 1,495,448,165 total voting rights cast. Notably, shares owned by J&A Alliance Trust represented 20% of the total voting power. The Trust is bound by a Shareholders Agreement that imposes voting restrictions, requiring it to vote shares in a manner proportional to the votes of shares not owned by the Trust in certain circumstances, such as a change in control transaction.

May 07, 2026 15:46:16

Aflac Reports Strong Q1 2026 Financial Performance and Returns

Aflac Incorporated reported total revenues of $4.3 billion for the first quarter of 2026, marking a 27.9% increase year-over-year. Net earnings reached $1.0 billion, or $1.98 per diluted share, significantly up from $29 million, or $0.05 per diluted share, in the same quarter last year. Adjusted earnings were $901 million, slightly down from $906 million a year ago, while adjusted earnings per diluted share increased by 5.4% to $1.75. The company returned $1.3 billion to shareholders through share repurchases and dividends, continuing its long-standing commitment to shareholder returns with a 5.2% increase in the quarterly dividend for Q2 2026.

In Japan, Aflac's net earned premiums decreased by 3.8% to ¥246.7 billion, influenced by external reinsurance transactions and product maturity. However, adjusted net investment income rose by 4.0%, and total new annualized premium sales increased by 25.5%, reflecting strong demand for newly launched products. In the U.S., net earned premiums grew by 3.5% to $1.6 billion, supported by improved sales of group products. Overall, the company reported a robust annualized return on average shareholders’ equity of 13.7% and an adjusted return on equity of 16.4% excluding foreign currency impacts.

Apr 29, 2026 16:19:50

Aflac Reports Q4 2025 Earnings and Dividend Increase

Aflac Incorporated reported its fourth quarter results for 2025, with total revenues of $4.9 billion, down from $5.4 billion in the same quarter of 2024. Net earnings for the fourth quarter were $1.4 billion, or $2.64 per diluted share, a decrease from $1.9 billion, or $3.42 per diluted share, a year earlier. The company noted net investment gains of $537 million for the quarter, compared to $1.0 billion in the previous year. For the full year, total revenues decreased 9.3% to $17.2 billion, while net earnings fell to $3.6 billion, or $6.82 per diluted share, down from $5.4 billion, or $9.63 per diluted share in 2024. Adjusted earnings for 2025 were $4.0 billion, or $7.49 per diluted share, slightly down from $4.1 billion, or $7.21 per diluted share in 2024.

The board of directors declared a first quarter dividend of $0.61 per share, reflecting a 5.2% increase, payable on March 2, 2026. In the fourth quarter, Aflac repurchased $800 million worth of its common shares, with 114.3 million shares remaining authorized for repurchase. The company's shareholders' equity at the end of 2025 was $29.5 billion, up from $26.1 billion a year prior. Aflac Japan reported a decline in net earned premiums, while Aflac U.S. experienced a 4.0% increase in net earned premiums for the fourth quarter. Overall, the company continues to focus on maintaining strong capital management and operational efficiencies.

Feb 04, 2026 16:20:42

Aflac Reports Significant Third Quarter Earnings and Dividend Declaration

Aflac Incorporated reported its third quarter financial results for 2025, revealing total revenues of $4.7 billion, a substantial increase from $2.9 billion in the same period of 2024. The company achieved net earnings of $1.6 billion, translating to $3.08 per diluted share, compared to a net loss of $93 million a year prior. This turnaround was largely attributed to net investment gains of $275 million, contrasting with significant losses in the previous year. Adjusted earnings for the quarter rose to $1.3 billion, or $2.49 per diluted share, marking a 9.6% increase year-over-year. Shareholders’ equity reached $28.7 billion, up from $24.8 billion a year ago, reflecting a strong annualized return on equity of 23.5% for the quarter.

The board of directors declared a fourth quarter dividend of $0.58 per share, scheduled for payment on December 1, 2025. In addition, Aflac repurchased $1.0 billion worth of its common shares during the third quarter, highlighting its commitment to returning capital to shareholders. The company reported improved performance in both its U.S. and Japan segments, with notable sales increases in cancer insurance products. Overall, Aflac's results indicate a robust financial position and ongoing efforts to enhance shareholder value through dividends and share repurchases.

Nov 04, 2025 16:38:48

Aflac Completes $2 Billion in Trust Securities Issuance

Aflac Incorporated has completed the issuance and sale of 1,000,000 Pre-Capitalized Trust Securities from two Delaware statutory trusts, Wynnton Funding Trust and Wynnton Funding Trust II, totaling $2 billion. The 2035 Trust issued securities redeemable on August 15, 2035, while the 2055 Trust issued redeemable securities on August 15, 2055. The arrangement includes a facility fee of 0.9875% per annum for the 2035 P-Caps and 1.1218% for the 2055 P-Caps, allowing Aflac to issue up to $1 billion of Senior Notes due in 2035 and 2055 respectively over specified periods.

The proceeds from this issuance will be invested in U.S. Treasury securities. Aflac is obligated to pay a semi-annual facility fee based on the unexercised portion of the Issuance Right, which can be exercised automatically under certain conditions, including failure to pay fees or a decline in net worth below $10 billion. The company may also redeem the Senior Notes at its discretion, impacting the timing and conditions under which the Trust Securities are redeemed.

Aug 27, 2025 16:32:08

Aflac Reports Second Quarter Earnings and Dividend Declaration

Aflac Incorporated reported its second quarter financial results for 2025, revealing total revenues of $4.2 billion, a decline from $5.1 billion in the same period last year. Net earnings were $599 million, or $1.11 per diluted share, down from $1.8 billion, or $3.10 per share a year ago, largely due to net investment losses of $421 million this quarter compared to gains of $696 million last year. The company’s adjusted earnings were $957 million, a decrease of 7.5% year-over-year, with adjusted earnings per diluted share falling by 2.7% to $1.78. Shareholders’ equity stood at $27.2 billion, up from $26.0 billion a year ago, despite net unrealized losses on investment securities and derivatives totaling $1.8 billion at the end of the quarter.

The board of directors declared a third quarter dividend of $0.58 per share, payable on September 2, 2025. Aflac Japan reported a 4.8% decrease in net earned premiums in yen, while Aflac U.S. saw a 3.4% increase in net earned premiums. Overall, total new annualized premium sales in Japan increased by 23.2%, driven by the introduction of a new cancer insurance product. The company repurchased $829 million in shares during the quarter and had 30.9 million shares remaining authorized for repurchase, indicating a commitment to returning capital to shareholders.

Aug 05, 2025 16:09:16

Aflac Reports Significant Decline in First Quarter Earnings

Aflac Incorporated announced its first quarter results for 2025, reporting net earnings of $29 million, a stark decrease from $1.9 billion in the same quarter of 2024. The total revenues for the quarter were $3.4 billion, down from $5.4 billion a year earlier, primarily due to net investment losses of $963 million compared to gains of $951 million in the previous year. Adjusted earnings were $906 million, reflecting a 5.7% decrease from the prior year, with adjusted earnings per diluted share remaining flat at $1.66. The company's shareholders' equity increased to $26.3 billion, or $48.55 per share, compared to $23.5 billion, or $41.27 per share, a year ago, largely due to changes in discount rate assumptions on insurance reserves.

In its Japan segment, Aflac reported a 5.0% decline in net earned premiums in yen terms, primarily due to specific internal transactions and policies reaching paid-up status. Adjusted net investment income also decreased by 7.6%. Conversely, net earned premiums in the U.S. increased by 1.8%, driven by improved sales and persistency. The board declared a second quarter dividend of $0.58 per share, payable on June 2, 2025. Additionally, Aflac repurchased $900 million worth of its common shares in the first quarter, with 38.8 million shares remaining authorized for repurchase.

Apr 30, 2025 16:43:17